Bell Michael Brian

Bell Michael Brian, Chief Financial Officer of GH (Guardant Health), has demonstrated a pronounced selling bias in his recent insider transactions, with no recorded purchases in the latest filings. Over 36 reported trades, his total sell transactions amount to $11.26 million, dwarfing his total buy value of $1.73 million. The selling activity has intensified recently, with 12 sales recorded since December 2025, including a significant $633,737 disposition on March 15, 2026, followed by a $261,111 sale the next day. Earlier, on December 5, 2025, he executed a series of sales totaling over $7.3 million, including a single transaction worth $2.34 million. All of Bell’s transactions involve GH, indicating concentrated activity in his company’s stock. While some filings show derivative transactions (coded "F" and "M") with no reported value, the outright sales (coded "S") dominate, particularly in late 2025 and early 2026. The absence of recent buys and the scale of disposals suggest a consistent reduction in his holdings. The pattern aligns with executives periodically liquidating equity for portfolio management, though the data does not disclose whether these sales were pre-planned or discretionary. The transactions reflect a clear directional trend toward divestment rather than accumulation.